Angion Biomedica Corp.
(NASDAQ GS: ANGN)
Rigrodsky Law, P.A. is investigating Angion Biomedica Corp. (“Angion”) regarding possible breaches of fiduciary duties and other violations of law related to Angion’s agreement to merge with Elicio Therapeutics, Inc.